Showing the single result
Zidovudine Tablet
FreeProduct Composition & Strength
We supply this product in standardized strengths optimized for both monotherapy (in specific PMTCT cases) and combination therapy (HAART).
Active Ingredient Strength Primary Clinical Target Zidovudine IP/BP/USP 300 mg The Foundation: Standard dose for adult HIV management. Excipients Pharma Grade The Matrix: Ensures shelf-life stability and rapid absorption.
